Jilin Aodong Pharmaceutical Group Co Ltd (000623) — Financial Flexibility Index
Jilin Aodong Pharmaceutical Group Co Ltd (000623) has a Financial Flexibility Index of 0.04x as of September 2025. Free cash flow of CN¥137.92 Million (operating CF CN¥112.12 Million minus capex CN¥25.80 Million) represents 0% of total liabilities (CN¥3.76 Billion). Also explore Jilin Aodong Pharmaceutical Group Co Ltd annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Jilin Aodong Pharmaceutical Group Co Ltd Financial Flexibility Index (1998–2024)
Historical Financial Flexibility Index trend for Jilin Aodong Pharmaceutical Group Co Ltd across 27 annual periods. Check Jilin Aodong Pharmaceutical Group Co Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Jilin Aodong Pharmaceutical Group Co Ltd (1998–2024)
Year-by-year free cash flow to debt coverage for Jilin Aodong Pharmaceutical Group Co Ltd. For the full company profile including market capitalisation, see Jilin Aodong Pharmaceutical Group Co Ltd market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.09x | CN¥333.47 Million | CN¥59.48 Million | CN¥3.72 Billion | ▼ -12.4% |
| 2023 | 0.10x | CN¥487.58 Million | CN¥68.06 Million | CN¥4.77 Billion | ▼ -28.9% |
| 2022 | 0.14x | CN¥694.82 Million | CN¥423.86 Million | CN¥4.83 Billion | ▼ -9.2% |
| 2021 | 0.16x | CN¥638.15 Million | CN¥324.85 Million | CN¥4.03 Billion | ▼ -1.9% |
| 2020 | 0.16x | CN¥617.79 Million | CN¥390.41 Million | CN¥3.82 Billion | ▼ -9.9% |
| 2019 | 0.18x | CN¥601.85 Million | CN¥379.46 Million | CN¥3.36 Billion | ▲ +3.3% |
| 2018 | 0.17x | CN¥592.94 Million | CN¥347.64 Million | CN¥3.41 Billion | ▼ -32.8% |
| 2017 | 0.26x | CN¥340.41 Million | CN¥256.49 Million | CN¥1.32 Billion | ▼ -23.0% |
| 2016 | 0.34x | CN¥491.84 Million | CN¥333.81 Million | CN¥1.47 Billion | ▲ +4.5% |
| 2015 | 0.32x | CN¥722.14 Million | CN¥388.03 Million | CN¥2.25 Billion | ▼ -48.4% |
| 2014 | 0.62x | CN¥690.84 Million | CN¥288.83 Million | CN¥1.11 Billion | ▲ +76.9% |
| 2013 | 0.35x | CN¥510.22 Million | CN¥201.22 Million | CN¥1.45 Billion | ▼ -29.1% |
| 2012 | 0.50x | CN¥599.20 Million | CN¥272.40 Million | CN¥1.21 Billion | ▼ -13.6% |
| 2011 | 0.57x | CN¥566.02 Million | CN¥108.30 Million | CN¥985.86 Million | ▲ +14.8% |
| 2010 | 0.50x | CN¥326.22 Million | CN¥174.22 Million | CN¥652.43 Million | ▲ +20.6% |
| 2009 | 0.41x | CN¥249.54 Million | CN¥213.03 Million | CN¥601.83 Million | ▼ -1.3% |
| 2008 | 0.42x | CN¥266.55 Million | CN¥235.03 Million | CN¥634.74 Million | ▼ -26.2% |
| 2007 | 0.57x | CN¥423.94 Million | CN¥384.69 Million | CN¥744.94 Million | ▲ +119.1% |
| 2006 | 0.26x | CN¥244.87 Million | CN¥187.99 Million | CN¥942.62 Million | ▲ +12.3% |
| 2005 | 0.23x | CN¥191.94 Million | CN¥136.26 Million | CN¥829.84 Million | ▼ -22.2% |
| 2004 | 0.30x | CN¥264.72 Million | CN¥218.53 Million | CN¥890.13 Million | ▼ -25.5% |
| 2003 | 0.40x | CN¥239.54 Million | CN¥147.65 Million | CN¥600.19 Million | ▲ +243.4% |
| 2002 | 0.12x | CN¥76.32 Million | CN¥-4.58 Million | CN¥656.68 Million | ▼ -87.6% |
| 2001 | 0.94x | CN¥346.13 Million | CN¥138.76 Million | CN¥369.87 Million | ▲ +26.3% |
| 2000 | 0.74x | CN¥240.94 Million | CN¥77.04 Million | CN¥325.19 Million | ▲ +92.2% |
| 1999 | 0.39x | CN¥180.70 Million | CN¥110.18 Million | CN¥468.69 Million | ▲ +93.1% |
| 1998 | 0.20x | CN¥42.42 Million | CN¥-30.90 Million | CN¥212.43 Million | — |